In our studies, the human cancer cell lines DU145 and MDA-MB-231 showed a strong reduction of c-Met phosphorylation, migration, and invasion when treated with the c-Met inhibitor BMS-777607 in the presence of commonly used concentrations of HGF (25–50 ng/mL). This evidence concerns the gene HGF and cancer.